Legionella pneumophila is a common cause of hospital-and community-acquired pneumonia. About 90% cases of legionellosis are due to this species, and the predominant serogroup (sg) 1 of L. pneumophila accounts for 84% of cases (15) . Legionella is present in naturally occurring and man-made water systems and is transmitted to humans by aerosol inhalation (2) . The source of infection can be identified by comparing environmental and clinical L. pneumophila isolates with a variety of typing methods. Pulsed-field gel electrophoresis (PFGE) is one of the most widely used typing methods and is generally considered to be highly discriminatory (5, (10) (11) (12) 14) . PFGE can identify unique strains of L. pneumophila with a specific PFGE profile; these strains are considered sporadic. Most reported cases of legionellosis in Europe are sporadic, as shown by the European Working Group on Legionella Infections (EWGLI) data set (http://www.ewgli.org/data/data yeardatatables.asp). Confirmed epidemic cases of legionellosis are defined as at least two cases arising from the same source and due to the same strain. The recovery of PGFEidentical isolates over long periods in given countries or continents suggests that some L. pneumophila clones are endemic (13) .
The presence of an endemic L. pneumophila sg 1 clone was suspected in 1997 when Lawrence et al. (9) reported that 33% of the cases of legionellosis identified in the Paris area between 1988 and 1997 were caused by a single L. pneumophila sg 1 strain. The cases had no apparent epidemiological links and were both hospital and community acquired. The same strain has since been repeatedly recovered throughout the Paris water distribution network. The distribution in France of this strain, designated L. pneumophila sg 1 strain Paris (CIP 107-629-T), is not known.
The French National Reference Center for Legionella (NRCL) collects all French clinical Legionella isolates and types them by conventional PFGE method by using the SfiI enzyme (9) . We reviewed here the epidemiological data on 691 clinical Legionella strains isolated in 118 different towns in France between January 1998 and December 2002.
Legionella pneumophila constituted 98.6% of the 691 isolates (Table 1) . L. pneumophila sg 1 was the predominant serogroup (90.0%), and sg 2 to 15 accounted for the remaining serogroups (10.0%). The most commonly isolated non-pneumophila species were L. longbeachae (four cases), L. anisa (four cases), and L. dumoffii and L. gormanii (one case each). This epidemiology is consistent with previous reports (8, 15) .
A total of 559 different PFGE patterns were obtained with the 691 isolates. Most patterns (n ϭ 543) were unique and corresponded to a single Legionella isolate; these were sporadic cases with no identified epidemiological link. Of the 691 isolates, 148 were associated with outbreaks or were linked to (Spain); and EUL 104 (Sweden). Figure 1 shows the pulsotypes of four of these strains; all of the European strains had the same profile, which was identical to the Paris strain except that it lacked a 680-kb fragment. This points to a widespread European distribution of an L. pneumophila sg 1 endemic clone. Endemic clones of L. pneumophila causing apparently unrelated cases of legionellosis have been identified by several authors (3, 4, 7, 10, 11, 13) . For instance, Selander et al. observed endemic Legionella clones with a wide geographical distribution in a study of the genetic structure of L. pneumophila populations by multilocus enzyme electrophoresis (13) . The clinical predominance of this strain could be due to its greater abundance in water distribution systems, to its higher virulence, or to its greater facility to be recovered from clinical specimens, although we have no evidence to support either of these hypotheses. Indeed, the PFGE type distribution of environmental L. pneumophila sg 1 strains is not as well characterized in France as that of clinical strains (environmental isolates are not systematically typed by PFGE). The multiplication rate, which could reflect the virulence of the Paris clone for human cells (1, 6) , is unknown. However, Lawrence et al. showed that patients infected by the Paris strain did not differ significantly from patients infected by other strains in terms of age, sex, risk factors, need for mechanical ventilation, or mortality (9) .
The Paris strain is known to colonize the entire water distribution network in the Paris area since 1987 (9), suggesting that this clone is well adapted to environmental survival. A review of NRCL data show that isolates with the Paris profile have also been isolated from the water distribution systems of at least 10 of the French towns in which clinical strains have been isolated. Other researchers have suggested that widespread geographical diffusion of Legionella strains may occur through rain and wind transportation (13) . The apparent spread of the Paris strain in France and Europe might simply reflect improved surveillance and recent routine application of molecular typing methods rather than being a recent phenomenon. The characteristics of the Paris strain appear to be very stable, since PFGE profiles remained stable among all French strains isolated between 1987 and 2002. The strict identity of all Paris isolates remains to be confirmed by multilocus sequence typing, a method based on DNA sequences that would allow us to compare the genetic background of the Paris strain to other clinical Legionella strains.
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